Differential Effects of Citrate Versus PPACK Anticoagulation on Measured Platelet Inhibition by Abciximab, Eptifibatide and Tirofiban Dean J. KereiakesTodd LorenzDavid R. Phillips OriginalPaper Pages: 123 - 127
Comparison of GP IIB/IIIA Inhibitors and Their Activity as Measured by Aggregometry, Flow Cytometry, Single Platelet Counting, and the Rapid Platelet Function Analyzer Axel C. MatzdorffGitta KühnelReinhard Voss OriginalPaper Pages: 129 - 139
A Synopsis of the Clinical Uses of Argatroban Mubina MoledinaMehdi ChakirPritesh J. Gandhi OriginalPaper Pages: 141 - 149
Protein and Angiogenic Dose-Response Expression of phVEGF-A165 Gene in Rat Myocardium Christer SylvénNondita SarkarKhalid Bin Islam OriginalPaper Pages: 151 - 156
Bedside Coagulometry During Intravenous Heparin Therapy after Coronary Angioplasty Anne Pauline SchroederLars Lyhne KnudsenJørgen Ingerslev OriginalPaper Pages: 157 - 163
Ecarin Clotting Time but not aPTT Correlates with PEG-Hirudin Plasma Activity Martin Moser MDJohannes Ruef MDChristoph Bode MD OriginalPaper Pages: 165 - 169
Platelet Reactivity in Coronary Ostial Blood: A Reflection of the Thrombotic State Accompanying Plaque Rupture and of the Adequacy of Anti-Thrombotic Therapy Samer S. Kabbani MDMatthew W. Watkins MDDavid J. Schneider MD OriginalPaper Pages: 171 - 176
Sulfonylureas Are Not Associated With Increased Mortality in Diabetics Treated With Thrombolysis for Acute Myocardial Infarction Amir Halkin MDArie Roth MDSolomon Behar MD OriginalPaper Pages: 177 - 184
Concurrent Use of Reteplase and Lepirudin in the Treatment of Acute Anterior Wall Myocardial Infarction Ilya Chern MDAshok Sharma MDDavid Dennis MD OriginalPaper Pages: 185 - 191